Prof. Benedikt Fischer

Academic nephrologist · Charité Berlin · Germany (DE) · Nephrology

Tier 1STK-0040GoodOwner MSL ABDr. Anna Becker

Data minimisation

Consent status: Recorded. The name shown may be a pseudonym. Contact details, personal identifiers and remuneration fields are hidden for your role; only scientific-profile fields needed for engagement planning are displayed.

Specialty: Thoracic oncology
Disease interests: IGAN
Scientific interests: Elderly patientsirAE managementBrain metastases
Engagement preference: Virtual
Advisory boards: 1
Publications: 3
Source system: Veeva CRM
Data quality: Good

Engagement plan

Cadence target for Tier 1: 4 per year (assumption)

Last engaged: 11 Sept 2026 (4 days ago)
Next planned contact: 11 Dec 2026
Last 6 months vs target: 100%
2 of 2 expected engagements

Insights from this stakeholder (1)

INS-0058Steroid-sparing strategies
11 Sept 2026 · Safety and tolerability
HighRouted

Engagement history (2)

All engagements including drafts, newest first

Date	Type	Format	MSL	Product	Topics	Insights	Flags	Status
11 Sept 2026	Investigator meeting	In person	Dr. Anna Becker	Nephrada	Steroid-sparing strategiesAPRIL pathway mechanism	1	Safety	Reviewed	ENG-0011
23 Mar 2026	Advisory board	Phone	Rachel Adeyemi	Vantrexa	PD-L1 testing turnaroundBrain-metastasis subgroup data+1	0	—	Reviewed	ENG-0091

Timeline

11 Sept 2026
Investigator meeting
Steroid-sparing strategies, APRIL pathway mechanism
23 Mar 2026
Advisory board
PD-L1 testing turnaround, Brain-metastasis subgroup data, Duration of response

Related stakeholders (2)

Charité Berlin

Dr. Emiko Vogel
Oncology pharmacist
Tier 3
Dr. Katarina Rossi
General neurologist
Tier 3